OpenAI's Miles Wang Quits to Launch AI Drug Startup at $2B
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the company to launch his own AI drug discovery startup.
- Wang is in talks to raise $200 million at a $2 billion valuation for the new venture.
Why it matters: A $2 billion pre-launch valuation for an AI drug discovery startup led by a single departing researcher reflects how aggressively capital is pricing AI-for-biology talent, and OpenAI loses a scientist working at the intersection of AI and the life sciences.
